Health X Platform per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
−₹6.35₹0.37−₹28.66₹2.79−₹22.70
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
−₹6.35₹0.37−₹28.66₹2.79−₹22.70
₹201.47₹201.47₹210.58₹314.22₹312.34
₹461.38₹414.73₹349.24₹432.47₹326.88
—−₹23.21−₹5.44₹12.00−₹32.85
−₹27.90−₹27.90−₹8.70₹7.52−₹41.63
3.23.23.23.23.2
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

HEALTHX₹278.80

Health X Platform Limited

· Pharma & Health
₹ CrorePeersSURAKSHAKRSNAANEPHROPLUS3BBLACKBIOMcap ₹887 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS-22.702.79-28.660.37-6.35
Diluted EPS-22.702.79-28.660.37-6.35
Book Value per Share312.34314.22210.58201.47201.47
Revenue per Share326.88432.47349.24414.73461.38
Cash Flow per Share-32.8512.00-5.44-23.21—
Free Cash Flow per Share-41.637.52-8.70-27.90-27.90
Shares Outstanding (cr)3.23.23.23.23.2
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.